Material permissible for research today could face stricter controls if it appears in non-research contexts
Nope - consistency is the only thing that matters
Key takeaways Modern medicine is continually advancing treatment options for many chronic health conditions
Head-to-head clinical evidence SURPASS-2: Mounjaro vs Ozempic in type 2 diabetes The SURPASS-2 trial, published in the New England Journal of Medicine, directly compared tirzepatide with semaglutide 1 mg (the standard Ozempic dose) in 1,879 people with type 2 diabetes over 40 weeks
How long does it take to see results with combination of GLP-1 and GIP
We acknowledged that some hospitals, ASCs and REHs may have expended resources to implement SDOH screenings, however, facilities that had already implemented such screenings prior to adoption of the measures would not have expended similar resources